ArticleCell death discovery2025
The dark side of the light (UVA): melanoma microenvironment and cell survival strategies.
Article in Cell death discovery, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- DHCR24 promotes endometrial carcinoma progression and is associated with cellular senescence regulation.Medical oncology (Northwood, London, England) · 2026Article
- Article
- The CpG island methylator phenotype defines an immune-cold and therapy-resistant subtype of cutaneous melanoma.Frontiers in immunology · 2026Article
- Immunomodulatory functions of growth differentiation factor 15 in skin aging and inflammatory dermatoses.Frontiers in immunology · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
The incidence of cutaneous melanoma is rapidly escalating in many developed countries, particularly among the aging populations. Extensive evidence shows epigenetic changes have a strong correlation between cutaneous malignant melanoma and exposure to sunlight, particularly its ultraviolet (UV) components, in the aging skin. While significant research has been conducted on aging and its associated Senescence-Associated Secretory Phenotype (SASP) contributed by senescent fibroblasts in old individuals, less is known about the role of UVA radiation in such SASP melanoma microenvironment, its effects on gene function, and the underlying mechanisms following UVA-induced DNA Damage (UDD). It is established that UVA radiation induces Double-Strand Breaks (DSBs) in DNA and activates checkpoint kinase 2 (Chk2) at these breaks, leading to p53-mediated apoptosis. But p53, beyond its role in regulating cell fate, its mutated form is also involved in the transcriptional regulation of potent pro-survival pathways by actively transcribing genes that counteract apoptosis in genetically abnormal melanoma cells. However, the molecular mechanisms that govern the fine balance between cell death and survival mediated by the p53 transcription factor under UVA exposure remain largely elusive. In this study, we report for the first time that UVA induces global DNA methylation as a compensatory mechanism in response to UVA-induced DNA Damage (UDD) in melanoma and melanocyte cells. However, melanoma cells in the vicinity of senescent fibroblasts under genotoxic stress are epigenetically altered by the paracrine secretion of interleukin-6 (IL-6) from senescent fibroblasts, which upregulates the anti-apoptotic gene GDF-15 as well as the DNA damage repair system. This upregulation occurs via hypomethylation of GDF-15 orphan CpG island promoters, followed by its active gene transcription of GDF-15 via both WT p53
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.